Top

European Journal of Nuclear Medicine and Molecular Imaging

04-01-2025 | Original Article

Mapping the knowledge landscape of the PET/MR domain: a multidimensional bibliometric analysis

Authors: Xiaofei Hu, Jianding Peng, Min Huang, Lin Huang, Qing Wang, Dingde Huang, Mei Tian

Published in: European Journal of Nuclear Medicine and Molecular Imaging

Abstract

Objective

This study aims to conduct a bibliometric analysis to explore research trends, collaboration patterns, and emerging themes in the PET/MR field based on published literature from 2010 to 2024.

Methods

A detailed literature search was performed using the Web of Science Core Collection (WoSCC) database with keywords related to PET/MR. A total of 4,349 publications were retrieved and analyzed using various bibliometric tools, including VOSviewer and CiteSpace.

Results

The analysis revealed an initial increase in PET/MR publications, peaking at 495 in 2021, followed by a slight decline. The USA, Germany, and China were the most prolific countries, with the USA demonstrating strong collaborative networks. Key institutions included the Stanford University, Technical University of Munich and University of Duisburg-Essen. Prominent authors were primarily from Germany, with significant contributions from University Hospital Essen. Major journals in the field included the European Journal of Nuclear Medicine, Journal of Nuclear Medicine, and Physics in Medicine and Biology. Emerging research areas focused on oncology, neurological disorders, and cardiovascular diseases, with keywords such as “prostate cancer,” “Alzheimer’s disease,” and “breast cancer” showing high research activity. Recent trends also highlight the growing integration of AI, particularly deep learning, to improve imaging reconstruction and diagnostic accuracy.

Conclusion

The findings emphasize the need for continuous investment, strategic planning, and technological innovations to expand PET/MR’s clinical applications. Future research should focus on optimizing imaging techniques, fostering international collaborations, and integrating emerging technologies like artificial intelligence to enhance PET/MR’s diagnostic and therapeutic potential in precision medicine.

Available only for authorised users

Koole M, Armstrong I, Krizsan AK, Stromvall A, Visvikis D, Sattler B, et al. EANM guidelines for PET-CT and PET-MR routine quality control. Z Med Phys. 2023;33:103–13.CrossRefPubMed

Weber W. Clinical PET/MR. Mol Imaging Oncol. 2020;747:64.

Lee SJ, Paeng JC, Goo JM, Lee JM, Cheon GJ, Lee DS, et al. Comparative characteristics of quantitative indexes for 18F-FDG uptake and metabolic volume in sequentially obtained PET/MRI and PET/CT. Nucl Med Commun. 2017;38:333–9.CrossRefPubMed

Singnurkar A, Poon R, Metser U. Comparison of 18F-FDG-PET/CT and 18F-FDG-PET/MR imaging in oncology: a systematic review. Ann Nucl Med. 2017;31:366–78.CrossRefPubMed

Krokos G, MacKewn J, Dunn J, Marsden P. A review of PET attenuation correction methods for PET-MR. EJNMMI Phys. 2023;10:52.CrossRefPubMedPubMedCentral

Shao Y, Cherry SR, Farahani K, Meadors K, Siegel S, Silverman RW, et al. Simultaneous PET and MR imaging. Phys Med Biol. 1997;42:1965–70. https://doi.org/10.1088/0031-9155/42/10/010.CrossRefPubMed

Slates Rea. Physics in medicine and biology 44 8. (1999): 2015.

Delso G, Fürst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. Journal of nuclear medicine: official publication. Soc Nuclear Med. 2011;52:1914–22. https://doi.org/10.2967/jnumed.111.092726.CrossRef

Balyasnikova S, Löfgren J, de Nijs R, Zamogilnaya Y, Højgaard L, Fischer BM. PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging. Am J Nucl Med Mol Imaging. 2012;2:458–74.PubMedPubMedCentral

10.

Roytman M, Kim S, Glynn S, Thomas C, Lin E, Feltus W, et al. PET/MR Imaging of Somatostatin Receptor Expression and Tumor Vascularity in Meningioma: implications for pathophysiology and tumor outcomes. Front Oncol. 2022;11. https://doi.org/10.3389/fonc.2021.820287.

11.

Kim DH, Oh M, Kim JS. Prediction of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Using Amyloid PET and Brain MR Imaging Data: A 48-Month Follow-Up Analysis of the Alzheimer’s Disease Neuroimaging Initiative Cohort. Diagnostics (Basel Switzerland). 2023;13. https://doi.org/10.3390/diagnostics13213375.

12.

Zhang XY, Yang ZL, Lu GM, Yang GF, Zhang LJ. PET/MR imaging: New Frontier in Alzheimer’s Disease and other dementias. Front Mol Neurosci. 2017;10:343. https://doi.org/10.3389/fnmol.2017.00343.CrossRefPubMedPubMedCentral

13.

Gal D, Glänzel W, Sipido KR. Mapping cross-border collaboration and communication in cardiovascular research from 1992 to 2012. Eur Heart J. 2017;38:1249–58. https://doi.org/10.1093/eurheartj/ehw459.CrossRefPubMed

14.

Sugimoto CR, Ahn YY, Smith E, Macaluso B, Larivière V. Factors affecting sex-related reporting in medical research: a cross-disciplinary bibliometric analysis. Lancet (London England). 2019;393:550–9. https://doi.org/10.1016/s0140-6736(18)32995-7.CrossRefPubMed

15.

Chen C, CiteSpace II. Detecting and visualizing emerging trends and transient patterns in scientific literature. 2006;57:359–77. https://doi.org/10.1002/asi.20317

16.

Mondal H, Deepak KK, Gupta M, Kumar R. The h-Index: understanding its predictors, significance, and criticism. J Family Med Prim care. 2023;12:2531–7. https://doi.org/10.4103/jfmpc.jfmpc_1613_23.CrossRefPubMedPubMedCentral

17.

Drzezga A, Souvatzoglou M, Eiber M, Beer AJ, Fürst S, Martinez-Möller A, et al. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med. 2012;53:845–55.CrossRefPubMed

18.

Delso G, Fürst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med. 2011;52:1914–22.CrossRefPubMed

19.

Berker Y, Franke J, Salomon A, Palmowski M, Donker HC, Temur Y, et al. MRI-based attenuation correction for hybrid PET/MRI systems: a 4-class tissue segmentation technique using a combined ultrashort-echo-time/Dixon MRI sequence. J Nucl Med. 2012;53:796–804.CrossRefPubMed

20.

Judenhofer MS, Wehrl HF, Newport DF, Catana C, Siegel SB, Becker M, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med. 2008;14:459–65.CrossRefPubMed

21.

Liu F, Jang H, Kijowski R, Bradshaw T, McMillan AB. Deep learning MR imaging–based attenuation correction for PET/MR imaging. Radiology. 2018;286:676–84.CrossRefPubMed

22.

Alberts IL, Sari H, Mingels C, Afshar-Oromieh A, Pyka T, Shi K et al. Long-axial field-of-view PET/CT: perspectives and review of a revolutionary development in nuclear medicine based on clinical experience in over 7000 patients. Cancer Imaging. 2023;23.

23.

Filippi L, Dimitrakopoulou-Strauss A, Evangelista L, Schillaci O. Long axial field-of-view PET/CT devices: are we ready for the technological revolution? Expert Rev Med Dev. 2022;19:739–43.CrossRef

24.

Sjöholm T, Ekström S, Strand R, Ahlström H, Lind L, Malmberg F, et al. A whole-body FDG PET/MR atlas for multiparametric voxel-based analysis. Sci Rep. 2019;9:6158. https://doi.org/10.1038/s41598-019-42613-z.CrossRefPubMedPubMedCentral

25.

Surti S. Update on Time-of-flight PET imaging. J Nuclear Med. 2015;56:105–98.CrossRef

26.

Research collaborations bring big. Rewards: the world needs more. Nature. 2021;594:301–2. https://doi.org/10.1038/d41586-021-01581-z.CrossRef

27.

Abumalloh RA, Nilashi M, Yousoof Ismail M, Alhargan A, Alghamdi A, Alzahrani AO, et al. Medical image processing and COVID-19: a literature review and bibliometric analysis. J Infect Public Health. 2022;15:75–93. https://doi.org/10.1016/j.jiph.2021.11.013.CrossRefPubMed

28.

Tomson G, Causevic S, Ottersen OP, Swartling Peterson S, Rashid S, Wanyenze RK, et al. Solidarity and universal preparedness for health after covid-19. BMJ (Clinical Res ed). 2021;372:n59. https://doi.org/10.1136/bmj.n59.CrossRef

29.

McGuire AL, Gabriel S, Tishkoff SA, Wonkam A, Chakravarti A, Furlong EEM, et al. The road ahead in genetics and genomics. Nat Rev Genet. 2020;21:581–96. https://doi.org/10.1038/s41576-020-0272-6.CrossRefPubMedPubMedCentral

30.

Afaq A, Fraioli F, Sidhu H, Wan S, Punwani S, Chen SH, et al. Comparison of PET/MRI with PET/CT in the evaluation of Disease Status in Lymphoma. Clin Nucl Med. 2017;42:e1–7. https://doi.org/10.1097/rlu.0000000000001344.CrossRefPubMedPubMedCentral

31.

Erdmann S, Niederstadt L, Koziolek EJ, Gómez JDC, Prasad S, Wagener A, et al. CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer. Theranostics. 2019;9:6719–33. https://doi.org/10.7150/thno.34857.CrossRefPubMedPubMedCentral

32.

Lyu Y, Chen X, Liu H, Xi Y, Feng W, Li B. Comparison of the diagnostic value of [(68) Ga]Ga-FAPI-04 PET/MR and [(18)F]FDG PET/CT in patients with T stage ≤ 2a2 uterine cervical cancer: a prospective study. Eur J Nucl Med Mol Imaging. 2024;51:1163–72. https://doi.org/10.1007/s00259-023-06539-z.CrossRefPubMed

33.

Burris NS, Johnson KM, Larson PE, Hope MD, Nagle SK, Behr SC, et al. Detection of small pulmonary nodules with Ultrashort Echo Time Sequences in Oncology patients by using a PET/MR system. Radiology. 2016;278:239–46. https://doi.org/10.1148/radiol.2015150489.CrossRefPubMed

34.

Cavaliere A, Giraudo C, Zuliani M, Cecchin D, Quaia E. 18F-FDG PET/MR in an atypical Pediatric Solid Pseudopapillary pancreatic tumor. Clin Nucl Med. 2019;44:e522–3. https://doi.org/10.1097/rlu.0000000000002671.CrossRefPubMed

35.

Ohno Y, Koyama H, Yoshikawa T, Takenaka D, Seki S, Yui M, et al. Three-way comparison of whole-body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-small Cell Lung Cancer patients. Radiology. 2015;275:849–61. https://doi.org/10.1148/radiol.14140936.CrossRefPubMed

36.

Theruvath AJ, Ilivitzki A, Muehe A, Theruvath J, Gulaka P, Kim C, et al. A PET/MR Imaging Approach for the Integrated Assessment of Chemotherapy-induced brain, heart, and bone injuries in Pediatric Cancer survivors: a pilot study. Radiology. 2017;285:971–9. https://doi.org/10.1148/radiol.2017170073.CrossRefPubMed

37.

Meng N, Jiang H, Sun J, Shen L, Wang X, Zhou Y, et al. Amide Proton transfer-weighted imaging and multiple models intravoxel incoherent motion-based (18) F-FDG PET/MRI for Predicting Progression-Free Survival in Non-small Cell Lung Cancer. J Magn Reson Imaging: JMRI. 2023. https://doi.org/10.1002/jmri.29037.CrossRefPubMed

38.

Kirchner J, Deuschl C, Schweiger B, Herrmann K, Forsting M, Buchbender C, et al. Imaging children suffering from lymphoma: an evaluation of different (18)F-FDG PET/MRI protocols compared to whole-body DW-MRI. Eur J Nucl Med Mol Imaging. 2017;44:1742–50. https://doi.org/10.1007/s00259-017-3726-0.CrossRefPubMed

39.

Bi S, Yan S, Chen Z, Cui B, Shan Y, Yang H, et al. Comparison of (18)F-FDG PET and arterial spin labeling MRI in evaluating Alzheimer’s disease and amnestic mild cognitive impairment using integrated PET/MR. EJNMMI Res. 2024;14:9. https://doi.org/10.1186/s13550-024-01068-8.CrossRefPubMedPubMedCentral

40.

Zhang M, Guan Z, Zhang Y, Sun W, Li W, Hu J, et al. Disrupted coupling between salience network segregation and glucose metabolism is associated with cognitive decline in Alzheimer’s disease - A simultaneous resting-state FDG-PET/fMRI study. NeuroImage Clin. 2022;34:102977. https://doi.org/10.1016/j.nicl.2022.102977.CrossRefPubMedPubMedCentral

41.

Liu SY, Qiao HW, Song TB, Liu XL, Yao YX, Zhao CS, et al. Brain microglia activation and peripheral adaptive immunity in Parkinson’s disease: a multimodal PET study. J Neuroinflamm. 2022;19:209. https://doi.org/10.1186/s12974-022-02574-z.CrossRef

42.

Pitombeira MS, Koole M, Campanholo KR, Souza AM, Duran FLS, Solla DJF, et al. Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study. Eur J Nucl Med Mol Imaging. 2022;49:4551–66. https://doi.org/10.1007/s00259-022-05899-2.CrossRefPubMed

43.

Schmitt J, Schwenck J, Maurer A, Przybille M, Sonanini D, Reischl G, et al. Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma. Theranostics. 2022;12:5615–30. https://doi.org/10.7150/thno.56736.CrossRefPubMedPubMedCentral

44.

Wurster TH, Landmesser U, Abdelwahed YS, Skurk C, Morguet A, Leistner DM, et al. Simultaneous [18F]fluoride and gadobutrol enhanced coronary positron emission tomography/magnetic resonance imaging for in vivo plaque characterization. Eur Heart J Cardiovasc Imaging. 2022;23:1391–8. https://doi.org/10.1093/ehjci/jeab276.CrossRefPubMed

45.

Marchesseau S, Seneviratna A, Sjöholm AT, Qin DL, Ho JXM, Hausenloy DJ, et al. Hybrid PET/CT and PET/MRI imaging of vulnerable coronary plaque and myocardial scar tissue in acute myocardial infarction. J Nuclear Cardiology: Official Publication Am Soc Nuclear Cardiol. 2018;25:2001–11. https://doi.org/10.1007/s12350-017-0918-8.CrossRef

46.

Mayer J, Wurster TH, Schaeffter T, Landmesser U, Morguet A, Bigalke B, et al. Imaging coronary plaques using 3D motion-compensated [(18)F]NaF PET/MR. Eur J Nucl Med Mol Imaging. 2021;48:2455–65. https://doi.org/10.1007/s00259-020-05180-4.CrossRefPubMedPubMedCentral

47.

Hulsen DJW, Mitea C, Arts JJ, Loeffen D, Geurts J. Diagnostic value of hybrid FDG-PET/MR imaging of chronic osteomyelitis. Eur J Hybrid Imaging. 2022;6:15. https://doi.org/10.1186/s41824-022-00125-6.CrossRefPubMedPubMedCentral

48.

Zhang Y, Cui B, Yang H, Ma J, Yang Y, Yang B, et al. Morphological feature and mapping inflammation in classified carotid plaques in symptomatic and asymptomatic patients: a hybrid (18)F-FDG PET/MR Study. Front NeuroSci. 2023;17:1144248. https://doi.org/10.3389/fnins.2023.1144248.CrossRefPubMedPubMedCentral

49.

Pedersen MA, Munk OLj, Dias AH, Steffensen JH, Møller AL, Johnsson AL et al. Dynamic whole-body [18F]FES PET/CT increases lesion visibility in patients with metastatic breast cancer. EJNMMI Res. 2024;14.

50.

Ulaner GA, Silverstein M, Nangia CS, Tetef M, Vandermolen L, Coleman C et al. ER-Targeted PET for initial staging and suspected recurrence in ER-Positive breast Cancer. JAMA Netw Open. 2024;7.

51.

Kuten J, Fahoum I, Savin Z, Shamni O, Gitstein G, Hershkovitz D, et al. Head-to-Head comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in staging prostate Cancer using histopathology and Immunohistochemical Analysis as a reference Standard. J Nuclear Med. 2019;61:527–32.CrossRef

52.

Civelek AC. 68Ga-PSMA-11 PET: better at detecting prostate Cancer than multiparametric MRI? Radiology. 2018;289 3:738–9.CrossRef

53.

Cohen AD, Klunk WE. Early detection of Alzheimer’s disease using PiB and FDG PET. Neurobiol Dis. 2014;72:117–22.CrossRefPubMed

54.

James OG, Linares AR, Hellegers C, Doraiswamy PM, Wong TZ. Evaluating Alzheimer Disease With Flortaucipir and Florbetapir PET: A Clinical Case Series. Clinical nuclear medicine. 2021.

55.

Dhawan V, Niethammer M, Lesser ML, Pappas K, Hellman M, Fitzpatrick T, et al. Prospective F-18 FDOPA PET imaging study in human PD. Nuclear Med Mol Imaging. 2022;56:147–57.CrossRef

56.

Stendahl JC, Kwan JM, Pucar D, Sadeghi MM. Radiotracers to address Unmet Clinical needs in Cardiovascular Imaging, Part 2: inflammation, fibrosis, thrombosis, calcification, and Amyloidosis Imaging. J Nuclear Med. 2022;63:986–94.CrossRef

57.

Maddahi J, Agostini D, Bateman TM, Bax JJ, Beanlands RSB, Berman DS, et al. Flurpiridaz F-18 PET myocardial perfusion imaging in patients with suspected coronary artery disease. J Am Coll Cardiol. 2023;82:161598–610.CrossRef

58.

Schaefferkoetter J, Yan J, Moon S, Chan R, Ortega C, Metser U, et al. Deep learning for whole-body medical image generation. Eur J Nucl Med Mol Imaging. 2021;48:3817–26. https://doi.org/10.1007/s00259-021-05413-0.CrossRefPubMed

59.

Huang Z, Liu H, Wu Y, Li W, Liu J, Wu R, et al. Automatic brain structure segmentation for (18)F-fluorodeoxyglucose positron emission tomography/magnetic resonance images via deep learning. Quant Imaging Med Surg. 2023;13:4447–62. https://doi.org/10.21037/qims-22-1114.CrossRefPubMedPubMedCentral

Title: Mapping the knowledge landscape of the PET/MR domain: a multidimensional bibliometric analysis
Authors: Xiaofei Hu
Jianding Peng
Min Huang
Lin Huang
Qing Wang
Dingde Huang
Mei Tian
Publication date: 04-01-2025
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-024-07043-8

Keynote webinar | Spotlight on adolescent vaping

Springer Medicine

Mapping the knowledge landscape of the PET/MR domain: a multidimensional bibliometric analysis

Abstract

Objective

Methods

Results

Conclusion

Keynote webinar | Spotlight on adolescent vaping

Springer Medicine

Abstract

Objective

Methods

Results

Conclusion

Please log in to get access to this content